Dermata is a scientific leader in dermatologic solutions that recently announced a strategic shift in focus to developing and distributing scientifically backed over-the-count (OTC) pharmaceutical products.

Our mission is to provide patients with access to efficacious and safe treatment options that meet the needs of patients. We aim to provide patients with products that are natural, by incorporating our Spongilla technology and know-how, with FDA listed OTC pharmaceutical ingredients to offer differentiated skin care solutions patients want to use. We see a growing demand for high-quality, scientifically proven OTC pharmaceutical products that empower patients to manage their skin health independently. We plan to initially launch a once-weekly acne kit with additional product candidates to follow for diseases like psoriasis and seborrheic dermatitis.

Check out a video from our founder and CEO, Gerry Proehl, with more detail on our decision to make this strategic pivot.